Here you’ll find interesting cases of eye conditions along with news and developments in the ophthalmology world.

Cases are presented as an initial image with history and examination. Health practitioners are encouraged to deduce the condition, before further investigations, diagnosis and management are presented.

We hope you find it as educational, informative and exciting as we do!

Click here to view our newsletter privacy notice.

Newsletter privacy notice

The information provided during signup is used by Eye Specialists Centre to send newsletters using the cloud-based software, Mailchimp. We do not disclose or share your personal data with other third party without your consent, or unless it is required by law. If you have any concerns about your privacy, please do not hesitate to ask.

Dr Michael Chilov and Dr Adrian Fung have presented lectures at the Royal Australian and New Zealand College of Ophthalmologists’ (RANZCOs’) 46th Annual Scientific Congress in Brisbane.

Dr Adrian Fung presents at RANCZO

Dr Adrian Fung was heavily involved at the recent Royal Australian and New Zealand College of Ophthalmologists 45th Annual Scientific Congress held in Hobart, Tasmania. At the Sunday breakfast symposium he presented data on patients with neovascular age-related macular degeneration and persistent fluid switched from intravitreal ranibizumab to aflibercept.

Visual and anatomical outcomes were found to improve after 6 months. However, it is uncertain if patients commenced on aflibercept would equally have improved if switched to ranibizumab. At the oncology symposium he presented two rare cases of choroidal neuroendocrine tumour and lymphoma. On Monday at the rapid fire session he presented a paper looking at the pitfalls of ultrasonography in measuring choroidal tumour thickness. Since the advent of enhanced-depth imaging optical coherence tomography, our accuracy in measuring choroidal tumours has increased. This has led to a revision in our thinking regarding measurement of choroidal tumour thickness.

Also presented was a paper on sclerochoroidal calcification, which due to a lack of choroidal involvement is probably better named scleral calcification. Finally, Dr Fung presented two posters on high-dose ranibizumab for neovascular age-related macular degeneration and solitary idiopathic choroiditis. High-dose ranibizumab (2.0mg) has the potential to improve outcomes in patients with recalcitrant fluid on standard dose (0.5mg) ranibizumab.


Have a question?   Call one of our clinics today.

© 2019-2020 Eye Specialists Centre | Privacy Policy | Disclaimer | Website design: WebInjection